Summary : Cerberus cashes out of Peninsula vaccine maker in $270 million deal
How this spinout from research deal aims to drug the undruggable
Bulk of genetic testing company’s 1,000 layoffs will be in S.F.
How this spinout from research deal aims to drug the undruggable
Bulk of genetic testing company’s 1,000 layoffs will be in S.F.